Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › X-linked retinitis pigmentosa

X-linked retinitis pigmentosa

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for X-linked retinitis pigmentosa

2 trials tracked for X-linked retinitis pigmentosa.

2Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 2
  1. Phase 2 A Clinical Trial of Retinal Gene Therapy for X-linked Retinitis Pigmentosa Using BIIB112 Completed
  2. Phase 2 Gene Therapy for X-linked Retinitis Pigmentosa (XLRP) - Retinitis Pigmentosa GTPase Regulator (RPGR) Completed

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
AAV-RPGR gene therapy improves retinal sensitivity in 73.8% of XLRP patients
Ophthalmology Meta-analysis
AAV-RPGR gene therapy improves retinal sensitivity in 73.8% of XLRP patients Gene therapy shows promise for patients with X-linked retinitis pigmentosa
This meta-analysis of 12 clinical reports assessed AAV-mediated RPGR gene augmentation in X-linked retinitis pigmentosa. Pooled data showed …
A new gene therapy shows significant improvements in retinal sensitivity and vision for people living with X-linked retinitis pigmentosa.
Aug 15, 2026